Combinent Biomedical Systems
Combinent Biomedical Systems focuses on the transvaginal delivery of drugs targeting women’s reproductive endocrinology disorders.
Launch date
Employees
Market cap
-
Enterprise valuation
$4—6m (Dealroom.co estimates Dec 2010.)
Lexington Kentucky (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$3.0m | Series A | ||
$500k | Debt | ||
N/A | $1.0m | Seed | |
N/A | $750k | Debt | |
N/A | $600k | Debt | |
Total Funding | $4.0m |